GlaxoSmithKline, Europe’s largest drugmaker, named 43-year-old Briton Andrew Witty as its new chief executive. Witty takes the helm from Frenchman Jean-Pierre Garnier next May. “He has the luxury of time, since he could be there for the best part of 20 years,” said analyst Peter Cartwright at Evolution Securities. (Reuters)
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Democrats: How to rebuild a damaged brandFeature Trump's approval rating is sinking, but so is the Democratic brand
-
Unraveling autismFeature RFK Jr. has vowed to find the root cause of the 'autism epidemic' in months. Scientists have doubts.
-
'Two dolls': Can Trump sell Americans on austerity?Feature Trump's tariffs may be threatening holiday shelves but they've handed Democrats a 'huge gift'
